We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$14.1B
1-Year Est. Return
30.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
SOLS
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.63% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRX
1426
Marex Group Limited Ordinary Shares
MRX
$4.65B
| $222K | ﹤0.01% |
+4,990
| New | +$197K |
|
1427
Benchmark Electronics
BHE
$3.04B
| $222K | ﹤0.01% |
+3,954
| New | +$213K |
|
1428
Dyne Therapeutics
DYN
$3.94B
| $221K | ﹤0.01% |
+12,208
| New | +$211K |
|
1429
Mercury Insurance
MCY
$5.86B
| $221K | ﹤0.01% |
+2,505
| New | +$224K |
|
1430
Sanofi
SNY
$105B
| $219K | ﹤0.01% |
+4,550
| New | +$212K |
|
1431
Andersons Inc
ANDE
$2.65B
| $219K | ﹤0.01% |
+3,045
| New | +$196K |
|
1432
Amneal Pharmaceuticals
AMRX
$5.78B
| $218K | ﹤0.01% |
17,556
+5,706
| +48% | +$76.6K |
|
1433
Korea Electric Power
KEP
$15.1B
| $218K | ﹤0.01% |
+15,285
| New | +$289K |
|
1434
BancFirst
BANF
$3.88B
| $217K | ﹤0.01% |
+1,997
| New | +$222K |
|
1435
First Bancorp
FBNC
$2.67B
| $217K | ﹤0.01% |
+3,845
| New | +$219K |
|
1436
Beam Therapeutics
BEAM
$2.81B
| $216K | ﹤0.01% |
9,069
+1,495
| +20% | +$41.5K |
|
1437
Verra Mobility
VRRM
$626M
| $216K | ﹤0.01% |
15,112
+2,489
| +20% | +$45.6K |
|
1438
OneSpaWorld
OSW
$2.68B
| $215K | ﹤0.01% |
+9,388
| New | +$200K |
|
1439
FB Financial Corp
FBK
$2.96B
| $215K | ﹤0.01% |
+4,147
| New | +$233K |
|
1440
Artisan Partners
APAM
$2.78B
| $215K | ﹤0.01% |
5,916
+949
| +19% | +$38.8K |
|
1441
Newmark Group
NMRK
$2.79B
| $215K | ﹤0.01% |
14,310
+2,711
| +23% | +$42.8K |
|
1442
DNOW Inc
DNOW
$2.6B
| $214K | ﹤0.01% |
18,000
+2,927
| +19% | +$39.6K |
|
1443
Tango Therapeutics
TNGX
$4.72B
| $214K | ﹤0.01% |
+10,238
| New | +$143K |
|
1444
ImmunityBio
IBRX
$8.45B
| $214K | ﹤0.01% |
27,849
+4,681
| +20% | +$32K |
|
1445
Ziff Davis
ZD
$1.93B
| $213K | ﹤0.01% |
5,076
-2,689
| -35% | -$98.9K |
|
1446
Minerals Technologies
MTX
$2.29B
| $212K | ﹤0.01% |
+2,993
| New | +$206K |
|
|
NVO
1447
Novo Nordisk
NVO
$218B
| $212K | ﹤0.01% |
5,772
+1,424
| +33% | +$67.5K |
|
1448
The Bancorp
TBBK
$2.79B
| $212K | ﹤0.01% |
3,937
+613
| +18% | +$36.7K |
|
1449
Boston Beer
SAM
$1.78B
| $212K | ﹤0.01% |
+918
| New | +$206K |
|
1450
NBT Bancorp
NBTB
$2.71B
| $210K | ﹤0.01% |
+4,934
| New | +$214K |
|
Similar funds
CM
ETC
BIP
FGP
BPC
SSA
TI
BBVA
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.